| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |